Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$9.1 million.

  • Rapid Micro Biosystems' Cash from Operations fell 524.42% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.7 million, marking a year-over-year increase of 1375.37%. This contributed to the annual value of -$44.2 million for FY2024, which is 205.85% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Cash from Operations stood at -$9.1 million, which was down 524.42% from -$9.7 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Cash from Operations ranged from a high of -$8.6 million in Q3 2024 and a low of -$19.3 million during Q3 2021
  • Over the past 5 years, Rapid Micro Biosystems' median Cash from Operations value was -$11.3 million (recorded in 2021), while the average stood at -$12.1 million.
  • In the last 5 years, Rapid Micro Biosystems' Cash from Operations tumbled by 14921.68% in 2021 and then skyrocketed by 4161.03% in 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Cash from Operations (Quarter) stood at -$12.9 million in 2021, then rose by 9.56% to -$11.7 million in 2022, then grew by 18.52% to -$9.5 million in 2023, then decreased by 4.34% to -$9.9 million in 2024, then increased by 8.66% to -$9.1 million in 2025.
  • Its Cash from Operations was -$9.1 million in Q3 2025, compared to -$9.7 million in Q2 2025 and -$9.1 million in Q1 2025.